Matthew Henn

Directeur Technique/Scientifique/R&D chez SERES THERAPEUTICS, INC.

Fortune : 47 133 $ au 30/04/2024

49 ans

Consumer Services

Health Technology

Postes actifs de Matthew Henn

Sociétés	Poste	Début	Fin
SERES THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	07/02/2019	-
SERES THERAPEUTICS, INC.	Corporate Officer/Principal	01/06/2012	07/02/2019

Sociétés	Poste	Début	Fin
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/03/2005	01/06/2012
Viral Genomics, Inc.	Directeur/Membre du Conseil	-	-

University of California, Berkeley	Doctorate Degree
University of New Hampshire	Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Corporate Officer/Principal	2
Doctorate Degree	1
Chief Tech/Sci/R&D Officer	1

Sectorielle

Consumer Services	3
Health Technology	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
SERES THERAPEUTICS, INC.	Health Technology

Entreprise privées	2
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Health Technology
Viral Genomics, Inc.

Entreprise privées

Health Technology

Viral Genomics, Inc.